Relationship Between Maternal Soluble Trigger Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Placenta Accreta Spectrum
NCT05376410 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2022-05-17
Summary
We planed to evaluate soluble the triggering receptors expressed on myeloid cell-1 (s TREM-1) levels in serum of pregnant women diagnosed with placenta accreta spectrum and compare it with healthy pregnant women's s TREM-1 serum levels.
Conditions
- Placenta Accreta, Third Trimester
Sponsors & Collaborators
-
Necmettin Erbakan University
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-11-14
- Primary Completion
- 2022-06-01
- Completion
- 2022-07-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Early Onset Preeclampsia and Nectin-4
NCT05098691 ·Status: COMPLETED
-
Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane
NCT02104791 ·Status: UNKNOWN
-
Investigating CD 71 in Preeclamptic Pregnancies
NCT06668545 ·Status: COMPLETED
-
Study of Placental Function in Healthy and Pathological Pregnancies
NCT02321007 ·Status: RECRUITING
-
Study of Placental Inflammation in Gestational Diabetes
NCT06884696 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prediction of Placenta Accreta Outcome in Pregnant Woman With Placenta Previa Using (hcg_h ) as Abiomarkers
NCT06761885 ·Status: NOT_YET_RECRUITING
-
Neutrophil Extracellular Traps Mediate Antiphospholipid Antibody-induced Pregnancy Loss
NCT03735108 ·Status: UNKNOWN
-
Prostasin Levels in Preeclamptic Women
NCT06623942 ·Status: COMPLETED
-
The Impact of Pregnancy and Pregnancy-associated Hypertension on Human Uterine Myometrial Artery Reactivity
NCT03888170 ·Status: WITHDRAWN
-
Role and Expression of MXRA5 in Placental Connective Tissue Remodelling in Preeclampsia
NCT04287998 ·Status: UNKNOWN
-
Screening for Intrapartum Fetal Compromise Using Placental Biomarkers
NCT07258329 ·Status: RECRUITING
-
The Placental Secretome as a Therapeutic Tool to Prevent Inflammation-induced Preterm Birth
NCT06891508 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mechanistic Underpinnings of Preeclampsia
NCT06567899 ·Status: NOT_YET_RECRUITING
-
Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss
NCT04455256 ·Status: COMPLETED
-
Vital Mechanism of NETs Formation vs. Suicidal Mechanism of NETs Formation During Normal Pregnancy and Preeclampsia
NCT05470712 ·Status: COMPLETED
-
sFlt-1:PlGF Ratio in Gestational Diabetes: PREDICTION (PREeclampsia in DIabetiC gestaTION) Study
NCT04877119 ·Status: UNKNOWN
-
State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 ·Status: UNKNOWN
-
The ADRB3 Receptor in Pregnancy
NCT02381106 ·Status: SUSPENDED
-
Plasma Concentration of Biological Markers in Placenta Accreta Spectrum
NCT04525534 ·Status: TERMINATED
-
Relaxin and Placental Volume in Placenta Accreta Spectrum
NCT06808165 ·Status: COMPLETED
-
First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction
NCT02879942 ·Status: COMPLETED
-
Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia
NCT06214702 ·Status: COMPLETED
-
Fetus Programming and Long Active Outcomes, Interaction Between Mother, Placenta and Fetus in Perinatal and Methabolic Disbalansces-focusing Diabetic Pregnancies
NCT07337759 ·Status: COMPLETED
-
Biochemical and Histological Changes in Pregnant Women With Preterm Premature Rupture of Membrane
NCT06639919 ·Status: COMPLETED
-
Analysis of the Levels of HLADR+ Extracellular Vesicles in Women With Preeclampsia as a Early Potential Biomarker
NCT06873737 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA